Envoy Medical (COCH) Total Liabilities (2021 - 2026)

Envoy Medical (COCH) has 6 years of Total Liabilities data on file, last reported at $19.3 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities fell 44.32% year-over-year to $19.3 million; the trailing twelve-month figure through Mar 2026 stood at $19.3 million (down 44.32% YoY), and the FY2025 full-year result was $20.3 million, down 33.1% from the prior year.
• Total Liabilities declined to $19.3 million in Q1 2026, from $20.3 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $39.8 million in Q2 2025 to a low of $10.0 million in Q4 2023.
• A 5-year average of $23.4 million and a median of $21.0 million in 2023 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities tumbled 74.07% in 2023 and surged 202.38% in 2024, its largest moves.
• Tracing COCH's Total Liabilities over 5 years: stood at $38.8 million in 2022, then plunged by 74.07% to $10.0 million in 2023, then surged by 202.38% to $30.4 million in 2024, then plunged by 33.1% to $20.3 million in 2025, then dropped by 5.19% to $19.3 million in 2026.
• Business Quant data shows COCH's Total Liabilities at $19.3 million in Q1 2026, $20.3 million in Q4 2025, and $15.7 million in Q3 2025.